NA
ICU icon

NewEdge Advisors’s SeaStar Medical ICU Stock Holding History

NewEdge Advisors’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$655 Buy
176
+1
+0.6% +$3 ﹤0.01% 3962
2025
Q4 		$420 Hold
175
– – ﹤0.01% 4084
2025
Q3 		$999 Buy
175
+148
+548% +$1.14K ﹤0.01% 3877
2025
Q2 		$116 Hold
27
– – ﹤0.01% 3898
2025
Q1 		$451 Hold
27
– – ﹤0.01% 3725
2024
Q4 		$528 Hold
27
– – ﹤0.01% 3647
2024
Q3 		$1.16K Hold
27
– – ﹤0.01% 3488
2024
Q2 		$2.06K Hold
27
– – ﹤0.01% 3325
2024
Q1 		$4.99K Buy
+27
New +$5.29K ﹤0.01% 3140

Other funds holding ICU

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

NewEdge Advisors's ICU Position: Q1 2026 in Review

NewEdge Advisors increased its SeaStar Medical (ICU) stake by 0.57% in Q1 2026, buying an estimated $3 and bringing the position to 176 shares worth $655. The position accounts for ﹤0.01% of the portfolio, ranked #3962.

NewEdge Advisors first reported a position in ICU in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.99K in Q1 2024. 17 funds tracked by Wall St. Rank hold ICU as of Q1 2026.

  • NewEdge Advisors held 176 shares of SeaStar Medical worth $655 as of Q1 2026.
  • NewEdge Advisors bought 1 SeaStar Medical share in Q1 2026, an estimated $3.
  • SeaStar Medical made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3962 holding.
  • NewEdge Advisors first reported a position in SeaStar Medical in Q1 2024 and has held it in 9 quarters since.
  • NewEdge Advisors's SeaStar Medical position peaked at $4.99K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.